Cargando…
MK2 is a therapeutic target for high-risk multiple myeloma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168486/ https://www.ncbi.nlm.nih.gov/pubmed/29567777 http://dx.doi.org/10.3324/haematol.2017.182121 |
| _version_ | 1783701886766940160 |
|---|---|
| author | Gu, Chunyan Cheng, Haibo Yang, Hongbao Bian, Yong Wang, Yaohui Zhang, Yifen Pisano, Michael Hu, Gang Yang, Ye |
| author_facet | Gu, Chunyan Cheng, Haibo Yang, Hongbao Bian, Yong Wang, Yaohui Zhang, Yifen Pisano, Michael Hu, Gang Yang, Ye |
| author_sort | Gu, Chunyan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8168486 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81684862021-06-11 MK2 is a therapeutic target for high-risk multiple myeloma Gu, Chunyan Cheng, Haibo Yang, Hongbao Bian, Yong Wang, Yaohui Zhang, Yifen Pisano, Michael Hu, Gang Yang, Ye Haematologica Letters to the Editor Fondazione Ferrata Storti 2018-03-22 /pmc/articles/PMC8168486/ /pubmed/29567777 http://dx.doi.org/10.3324/haematol.2017.182121 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Gu, Chunyan Cheng, Haibo Yang, Hongbao Bian, Yong Wang, Yaohui Zhang, Yifen Pisano, Michael Hu, Gang Yang, Ye MK2 is a therapeutic target for high-risk multiple myeloma |
| title | MK2 is a therapeutic target for high-risk multiple myeloma |
| title_full | MK2 is a therapeutic target for high-risk multiple myeloma |
| title_fullStr | MK2 is a therapeutic target for high-risk multiple myeloma |
| title_full_unstemmed | MK2 is a therapeutic target for high-risk multiple myeloma |
| title_short | MK2 is a therapeutic target for high-risk multiple myeloma |
| title_sort | mk2 is a therapeutic target for high-risk multiple myeloma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168486/ https://www.ncbi.nlm.nih.gov/pubmed/29567777 http://dx.doi.org/10.3324/haematol.2017.182121 |
| work_keys_str_mv | AT guchunyan mk2isatherapeutictargetforhighriskmultiplemyeloma AT chenghaibo mk2isatherapeutictargetforhighriskmultiplemyeloma AT yanghongbao mk2isatherapeutictargetforhighriskmultiplemyeloma AT bianyong mk2isatherapeutictargetforhighriskmultiplemyeloma AT wangyaohui mk2isatherapeutictargetforhighriskmultiplemyeloma AT zhangyifen mk2isatherapeutictargetforhighriskmultiplemyeloma AT pisanomichael mk2isatherapeutictargetforhighriskmultiplemyeloma AT hugang mk2isatherapeutictargetforhighriskmultiplemyeloma AT yangye mk2isatherapeutictargetforhighriskmultiplemyeloma |